Indole‐3‐Lactic Acid Inhibits Doxorubicin‐Induced Ferroptosis Through Activating Aryl Hydrocarbon Receptor/Nrf2 Signalling Pathway
Journal of Cellular and Molecular Medicine · 2025-01 · 29 (2)
DOI: 10.1111/jcmm.70358 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 23.01.2025. Verfasst von Jiangfang Lian und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Affiliated Lihuili Hospital of Ningbo University, Zhejiang, China. Hauptthemen laut MEDLINE: Ferroptosis, Receptors, Aryl Hydrocarbon, NF-E2-Related Factor 2, Signal Transduction. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhejiang ProvincialNatural Science Foundation of China, National Natural Science Foundation of China, Medical Health Science and Technology Project of Zhejiang Provincial.
Abstract (Originalsprache)
The clinical application of doxorubicin (DOX) is limited due to its cardiotoxicity, which is primarily attributed to its interaction with iron in mitochondria, leading to lipid peroxidation and myocardial ferroptosis. This study aimed to investigate the role of the gut microbiota‐derived metabolite, indole‐3‐lactic acid (ILA), in mitigating DOX‐induced cardiotoxicity (DIC). Cardiac function, pathological changes, and myocardial ferroptosis were assessed in vivo. The cardioprotective effects and mechanisms of ILA were explored using multi‐omics approaches, including single‐nucleus RNA sequencing (snRNA‐seq) and bulk RNA‐seq, and were further validated in Nrf2 knockout mice. The findings revealed that DOX treatment disrupted gut microbiota, significantly reducing the levels of the tryptophan metabolite ILA. In DIC models, ILA supplementation markedly improved cardiac function, reduced collagen deposition, and mitigated cardiac atrophy. The bulk and snRNA‐seq analyses indicated that myocardial ferroptosis played a crucial role in the cardioprotective effects of ILA. Experimental data demonstrated that ILA decreased DOX‐induced ferroptosis in both DIC mice and DOX‐treated H9C2 cells, evidenced by restoration of GPX4 and SLC7A11 levels and reduction of ACSL4. Mechanistically, ILA functions as a ligand for the aryl hydrocarbon receptor (AhR), leading to the upregulation of Nrf2 expression. The protective effects of ILA against ferroptosis were abolished by silencing AhR. Moreover, the beneficial effects of ILA on DIC were eliminated in Nrf2‐deficient mice. In conclusion, ILA exerts therapeutic effects against DIC by inhibiting ferroptosis through activation of the AhR/Nrf2 signalling pathway. Identifying the cardioprotective role of the microbial metabolite ILA could offer viable therapeutic strategies for DIC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, The Affiliated Lihuili Hospital of Ningbo University, Zhejiang, China.
- Central Laboratory of Medicine, Shaoxing People's Hospital, Shaoxing, China.
- College of Medicine, Shaoxing University, Shaoxing, China.
- Department of Cardiology, Enze Medical Research Center, Taizhou Hospital Affiliated to Wenzhou Medical University, Linhai, China.
- Department of Gynaecology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
- Department of Cardiology, Zhuji People's Hospital of Zhejiang Province, Zhuji Affiliated Hospital of Wenzhou Medical University, Zhuji, China.
ORCID-Profile: Hui Lin, Jufang Chi, Liping Meng
Förderung
- Zhejiang ProvincialNatural Science Foundation of China
- National Natural Science Foundation of China
- Medical Health Science and Technology Project of Zhejiang Provincial
- Ningbo Municipal Key Laboratory for Molecular Target Screening and Applications
- Ningbo Major Research and Development Plan Project
Zitieren
APA
Lian, J., Lin, H., Zhong, Z., Song, Y., Shao, X., Zhou, J., Xu, L., Sun, Z., Yang, Y., Chi, J., Wang, P., & Meng, L. (2025). Indole‐3‐Lactic Acid Inhibits Doxorubicin‐Induced Ferroptosis Through Activating Aryl Hydrocarbon Receptor/Nrf2 Signalling Pathway. Journal of Cellular and Molecular Medicine, 29(2). https://doi.org/10.1111/jcmm.70358
Vancouver
Lian J, Lin H, Zhong Z, Song Y, Shao X, Zhou J, et al. Indole‐3‐Lactic Acid Inhibits Doxorubicin‐Induced Ferroptosis Through Activating Aryl Hydrocarbon Receptor/Nrf2 Signalling Pathway. Journal of Cellular and Molecular Medicine. 2025;29(2). doi:10.1111/jcmm.70358
BibTeX
@article{Lian2025,
author = {Lian, Jiangfang and Lin, Hui and Zhong, Zuoquan and Song, Yongfei and Shao, Xian and Zhou, Jiedong and Xu, Lili and Sun, Zhenzhu and Yang, Yongyi and Chi, Jufang and Wang, Ping and Meng, Liping},
title = {Indole‐3‐Lactic Acid Inhibits Doxorubicin‐Induced Ferroptosis Through Activating Aryl Hydrocarbon Receptor/Nrf2 Signalling Pathway},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
volume = {29},
number = {2},
doi = {10.1111/jcmm.70358}
}
EUVIMED